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Coupling of transcription and alternative splicing via regulation of the transcriptional elongation
rate is a well-studied phenomenon. Template features that act as roadblocks for the progression
of RNA polymerase II comprise histone modifications and variants, DNA-interacting proteins and
chromatin compaction. These may affect alternative splicing decisions by inducing pauses or
decreasing elongation rate that change the time-window for splicing regulatory sequences to be
recognized. Herein we discuss the evidence supporting the influence of template structural
modifications on transcription and splicing, and provide insights about possible roles of non-B
DNA conformations on the regulation of alternative splicing.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The unpacked DNA content in a single nucleus of human diploid
cells is around 2 m long, since the distance between consecutive
base pairs is 0.34 nm and our genome is 6  109 bp-long. Thus,
to fit inside a 10 lm-diameter nucleus, DNA is highly condensed
in a nucleoprotein complex named chromatin, organized in nucle-
osomes, each of which wraps 147 bp of DNA in two turns around a
histone octamer, which implies a 40-fold DNA length reduction.
These octamers are composed by two H3–H4 and two H2A–H2B
dimers, and an additional histone H1 that protects the internucle-
osomal DNA linker. Further condensation is obtained by supercoil-
ing of DNA. This condensation is not arbitrary, and DNA inside the
nucleus is organized in functional domains comprising regions that
are transcribed and regions that remain silent [1].
Gene expression, as other processes involving the information
encoded in DNA, implies local and transient changes in chromatin
structure: nucleosomes have to disassemble and the DNA double
helix has to melt for RNA polymerase II to generate a complemen-
tary RNA strand. Parameters like the underlying DNA sequence and
its chemical modifications, chromatin composition and com-
paction, as well as post-translational modifications (PTMs) of his-
tones, affect transcription by two means: either by the specific
recruitment of factors that interact with RNAPII, the nascent RNAor chromatin itself, or simply by affecting RNAPII elongation rate
along genes.
This review will focus on DNA and chromatin structures, tran-
scriptional regulation and their influence on mRNA processing.
2. Transcription
RNA polymerase II (RNAPII) is the enzyme responsible of
the synthesis of mRNA and many non-coding RNAs (ncRNAs).
Similarly to RNA polymerases I and III, the other two mam-
malian DNA-dependent RNA polymerases, RNAPII has a large
subunit in which resides the catalytic activity, and a set of
other essential structural subunits. Distinctively, its large sub-
unit, Rpb1, has a rather unique carboxy-terminal domain
(CTD) composed of 52 repeats of the heptapeptide consensus
YSPTSPS [2,3]. This domain acts as an interacting platform
for factors involved in regulation of transcription and the four
main processes coupled to it: capping, splicing, polyadenylation
[4] and termination [5].
The 7 amino acids composing each CTD repeat can suffer post-
translational modifications (PTMs). Tyrosines, threonines and seri-
nes can be phosphorylated. Threonines and serines can be glycosy-
lated. Non-consensus residues, such as arginines and lysines can be
ubiquitylated, acetylated, SUMOylated or methylated. Also, proli-
nes can be isomerized between their cis- and trans-
conformations [4,6]. These PTMs have been shown to be essential
to modulate CTD’s interactions with its partners, and therefore
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For more detailed reviews on RNAPII CTD, transcription and pro-
cessing, see [2,4,6].
As the first step of gene expression, transcription of DNA into
mRNA by RNAPII is a tightly regulated process. It starts with the
binding of TBP to the promoter and the subsequent binding of
other General Transcription Factors (GTFs) in a stepwise fashion.
RNAPII is recruited, constituting the pre-initiation complex (PIC).
Following, TFIIE and TFIIH are added to the PIC and allow promoter
melting to start transcription [7]. Within the first 30–60 bp down-
stream transcription start site (TSS) RNAPII tends to get paused and
accumulate in a highly stable complex in what is known as the pro-
moter proximal pause. Paused RNAPII is stabilized by NELF and
DSIF. Release of this pause is triggered by the action of the tran-
scription elongation factor P-TEFb that phosphorylates NELF, DSIF
and RNAPII CTD in Ser2 [8]. Interestingly, it was recently published
that this checkpoint that allows the switch to productive elonga-
tion is not limited to genes exhibiting a promoter proximal pause,
but is a general feature of all genes [5].
For years, a simplistic model has been accepted referring to
RNAPII phosphorylation, according to which Ser5 phosphorylation
(Ser5P) by Cdk7, as part of TFIIH was a hallmark of transcription
initiation, whereas Ser2P by Cdk9, as part of P-TEFb, was the hall-
mark of elongation. However, the actual picture is much more
complex. The Carmo-Fonseca and Proudfoot groups recently
reported a high-throughput analysis of RNAPII phosphorylation
based on native elongating transcript sequencing (NET-seq) [9].
They found that the CTD is poorly phosphorylated at the tran-
scription start site, but acquires both Ser2P and Ser5P at the
beginning of the gene. Besides, at the end of the gene, Ser2P
becomes predominant. Surprisingly, they detected high peaks of
Ser5P in exons, suggesting that this modification may induce a
pause in transcription to allow the nascent exon to be recognized
by the splicing machinery. Though fundamental, this approach
still does not provide information about the association of differ-
ent combinatorial CTD modifications and the dynamics of
transcription.
The average elongation rate of RNAPII along the genes is around
2–3 kb/min, but its actual speed is highly variable. In fact, GRO-seq
analyses showed a 4-fold variation in elongation rates of different
17-b estradiol and TNF-a inducible genes. Moreover, RNAPII
increases its elongation rate as it transcribes along the genes
[10], presumably a consequence of a gradual maturation of the
elongation complex. John Lis’ group confirmed this in a genome-
wide scale using GRO-seq in combination with RNAPII initiation
or promoter-proximal pause escape inhibition with triptolide or
flavopiridol, respectively. This allowed them to perform a multi-
variate analysis to determine the influence of different gene fea-
tures in RNAPII elongation rates. Exon density, CpG content and
methylation, as wells as H3K79me2 levels, showed up as the main
factors that regulate elongation, while the contribution of other
factors like promoter architecture, nucleosome occupancy and
other chromatin marks appeared to be secondary. Moreover, when
focusing on what happens at specific points in the gene body, they
noticed a decrease in elongation rate in exons [11,12], consistent
with a role of elongation rate in splicing. This result is in agreement
with the splicing-dependent pause in transcription reported by
Beggs and colleagues [13].
3. Transcription and alternative splicing
Splicing of pre-mRNA consists in the concerted removal of
internal sequences of the pre-mRNA (i.e. introns) and ligation of
sequences that are part of the mature mRNA (i.e. exons). This pro-
cess is catalyzed by the spliceosome, a ribonucleoprotein complex
[14] highly conserved in eukaryotes, and occurs in virtually all ofour genes. Alternative splicing is the mean by which two or more
different mRNAs can be produced from a single gene by the alter-
native inclusion/exclusion of particular sequences of the pre-
mRNA. Thus, a single gene can produce protein isoforms with dif-
ferent and even opposite functions. As an example, the exclusion of
an alternative sequence of Bcl-x gene results in a shorter protein
that acts as a dominant negative, competing with the full-length
protein that has a role in promoting apoptosis [15]. It is estimated
that around 95% of our genes are affected by alternative splicing,
the main mechanism by which a huge diversity of proteins is
obtained from a limited number of genes. This property helps to
explain the fact that animals of different complexity levels have
a similar number of genes. For instance, while humans have
19.000 genes, Drosophila melanogaster has 14.000 genes and
Caenorhabditis elegans has 20.000 genes, the proportion of genes
affected by alternative splicing is much higher in humans (95%)
[16], than in Drosophila (46%) [17] or C. elegans (25%) [18].
As mentioned above, RNAPII elongates the nascent transcript at
an average of 2–3 kb/min, but its speed suffers dramatical changes
along the gene. Diverse trans- and cis-acting factors have been
reported to regulate RNAPII elongation, either by steric interaction,
or by acting as co-activators/co-inhibitors or introducing PTMs to
the elongation complex. Multiple lines of evidence confirm that
splicing is mostly co-transcriptional. These include deep-
sequencing of nascent transcripts [9,19] and the detection of
mRNAs already spliced, components of the spliceosome and splic-
ing factors in the chromatin fraction [20–25]. Moreover, pre-mRNA
splicing is coupled to transcription, meaning there is a crosstalk
between these two processes by which they influence each other
[26]. Although coincidence in time of transcription and splicing is
probably a need for coupling, simultaneous occurrence of these
processes is not sufficient to guarantee the mutual influence of
the transcription and splicing machineries [27].
Coupling of transcription and splicing has been demonstrated
by the fact that transcription by an RNAPII lacking its CTD results
in inefficient splicing [28]. This was further confirmed by the find-
ing that the same transcriptional unit, comprising an alternative
exon, shows different alternative exon inclusion/exclusion ratios
under the control of different RNAPII promoters [29,30]. Also, tran-
scription factors [31,32], coactivators [33], transcription enhancers
[34], and proteins with dual activity as transcription and splicing
factors [35] as well as chromatin remodelers [36] and factors that
alter chromatin structure [37–39] modulate alternative splicing.
Two alternative models have been proposed to explain the cou-
pling of transcription and alternative splicing: the kinetic coupling
model and the recruitment model (Fig. 1). The proposal of two
alternative models has a rather illustrative objective, for it is evi-
dent that not only these models are not mutually exclusive, but
also what most probably happens is a combination of both.
One of the determining factors in coupling of transcription and
splicing is the kinetics at which transcript elongation occurs. As
splicing sites and regulatory sequences on the RNA (splicing
enhancers and silencers) emerge, these are recognized by the
spliceosome machinery and splicing factors. Sequences that induce
pauses on transcription [40], as well as chromatin compaction and
presence of factors that block RNAPII [39], increase the time win-
dow for weak splicing sites to be recognized before a strong site
located downstream is synthesized (Fig. 1A). On the other hand,
a high elongation rate gives more chances for strong sites to be rec-
ognized over weak sites.
Depending on the context, low elongation rates or transcrip-
tional pauses within an alternative exon or its downstream intron
can induce an increase or a decrease in exon inclusion. For
instance, if the alternative exon is preceded by a weak 30 splice site
(30-SS) and the downstream exon by a strong 30-SS, a low elonga-
tion rate will promote exon inclusion, as happens with the exon
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Fig. 1. Coupling of transcription and alternative splicing can be explained by two non mutually exclusive models. (A) The rate of transcriptional elongation can affect
alternative splicing decisions in the context of the kinetic coupling model. In the example represented, an alternative exon is flanked by a weak 30 splice site (30-SS) followed
by a constitutive exon flanked by a strong 30-SS. At high transcriptional elongation rates, there is a short time window between the synthesis of both 30-SS, and the strong 30-
SS competes with the weak 30-SS for the commitment of the splicing machinery, promoting alternative exon skipping. On the other hand, when the transcription elongation
rate is low, there is more time for the weak 30-SS to be recognized before the strong 30-SS is synthesized, promoting exon inclusion. (B) In the recruitment model, splicing
factors that are recruited to the transcription machinery can affect alternative splicing decisions. In the example depicted, the splicing factor SRSF3 interacts with RNAPII CTD
and inhibits the inclusion of the alternative exon into the mature mRNA.
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splice sites, but inclusion of the alternative exon is negatively reg-
ulated by an splicing silencer placed in the upstream intron, a low
elongation rate will increase the opportunity of this regulatory ele-
ment to be recognized favoring exon skipping. This is the case of
exon 9 of the CFTR gene, whose exclusion is induced by a low elon-
gation rate [41].
The kinetic coupling of transcription and alternative splicing
has been corroborated by multiple approaches. In 1998, Roberts
et al. showed that the insertion of DNA sequences that induce
pauses in transcription modulate alternative splicing. Their work-
ing model was a minigene containing the alternative exon 3 of
a-tropomyosin, whose splicing is modulated by two regulatory
elements, one upstream and one downstream of exon 3 (named
URE and DRE, respectively). Exclusion of exon 3 is mediated by
the binding of a protein complex to both regulatory elements.
Thus, they reasoned that a delay in the synthesis of the DRE would
result in higher inclusion of exon 3. To test this hypothesis, they
cloned, in the downstream intron, but upstream the DRE, three dif-
ferent DNA sequences previously reported to induce pauses in
transcription: the C2 and a2 elements of the human complement
C2 and a-globin genes and a four tandem repeat of G5AG5
(MAZ4), the consensus sequence for the binding of MAZ zinc finger
protein. Consistently with their hypothesis, all three pause ele-
ments induced an upregulation of exon 3 inclusion [40], thus
becoming the first evidence of pause elements affecting alternative
splicing decisions. Alternative splicing regulation by a transcription
pause site was also shown to happen in Bcl-x gene, in which the
factor TCERG1 promotes elongation and reduces the effect of this
pause [42].
Further evidence of kinetic coupling was given by the use of
drugs or agents that inhibit elongation, such as UV irradiation ofthe cells [43], DRB and campothecin [44], as well as by the use of
drugs that loosen chromatin structure, and thereby allow a faster
elongation speed [39] or factors that promote elongation [32].
The most direct demonstration of the kinetic coupling implied
the use of slow RNAPII mutants. One of these polymerases was ini-
tially described in D. melanogaster [45], and bears a single amino
acid substitution in the large catalytic subunit Rpb1. Greenleaf
and coworkers showed that the slower elongation rate of this RNA-
PII mutant, named C4, is not due to lower catalysis, but to higher
difficulties to overcome pauses, and its decreased elongation rate
has been confirmed to occur in vivo [46]. Transcription by this
polymerase increased fibronectin E33 inclusion, consistently with
the kinetic coupling model. Also, it alters alternative splicing of
the gene ultrabithorax (Ubx) in D. melanogaster [47]. Thus, this
polymerase became a suitable and versatile tool to evaluate kinetic
effects on alternative splicing, and reinforces the idea that tran-
scriptional pauses play an important role in alternative splicing
decisions.
On the other hand, the transcriptional machinery can interact
with factors that affect splicing, which illustrates the recruitment
model of coupling. The carboxy-terminal domain of RNAPII (CTD)
plays a fundamental role [4], as it works as an interacting platform
for factors that affect splicing [48]. Interestingly, these factors can
be recruited even in the transcriptional promoter [49]. An illustra-
tive example of the role of the CTD in the recruitment of splicing
factors is given by the SR protein SRSF3 (formerly named SRp20):
this splicing factor inhibits E33 inclusion and its knockdown pre-
vents this effect promoting its inclusion (Fig. 1B). When the gene
is transcribed by a mutant RNAPII lacking the CTD, knockdown of
SRSF3 has no effect, suggesting that its interaction with the CTD
is necessary to recruit SRSF3 [50]. Although constitutive splicing
occurs co-transcriptionally, catalysis of alternative splicing is often
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factors that alter splicing are recruited co-transcriptionally to the
nascent pre-mRNA [52].
An example in the interface of both models is given by the
DBIRD complex. This complex interacts with the nascent transcript
and the transcribing RNAPII and promotes skipping of an alterna-
tive exon by enhancing elongation through AT-rich sequences.
When DBIRD components are knocked-down, RNAPII elongates
slower through these regions and alternative splicing patterns
change [53].
4. How the template affects transcription and alternative
splicing
As discussed above, RNAPII elongation rate and pauses imposed
to transcription constitute important factors in the regulation of
alternative splicing. Thus, in this section we will discuss the DNA
and chromatin features, such as histone variants and PTMs, DNA
methylation and DNA structure that affect transcription and there-
fore play a role in alternative splicing decisions.
4.1. Histone modifications and nucleosomes
Chromatin constitution has become, in the last years, one of
the most studied factors that modulate transcription. Histones
suffer PTMs such as methylation, acetylation, phosphorylation
and ubiquitylation, among others. These PTMs can occur both in
the amino acids forming part of the core of histones or in their
protruding amino-terminal tails (also named histone tails), being
the latter the most studied. Histone core PTMs affect chromatin
structure by modifying the histone–DNA and histone–histone
interactions and thereby altering the compaction of chromatin,
what in turn leads to changes in regulation of processes involving
DNA, including transcription. Also, these modifications may affect
the binding of histone chaperones [54]. The histone tails are 40
amino acid domains that protrude from the nucleosomes. These
domains, rich in basic amino acids, are subject of a variety of
PTMs. Lysine modifications on histone tails, in particular acetyla-
tion and methylation, are the best characterized PTMs. Arginines
can also be methylated, and histone tails suffer other modifica-
tions such as phosphorylation, glucosamination, ubiquitylation,
SUMOylation and polyADPribosylation. These modifications act
as adaptors for the binding of proteins. For example, the chro-
matin remodeler CHD1 binds to tri-methylated lysine 4 of H3
[55], while heterochromatin protein 1 (HP1) binds to H3K9me3
[56]. It is unclear whether modifications of histone tails have an
effect per se aside from the recruitment of specific factors. Some
authors claim that the change in histone tails net charge by
acetylation or phosphorylation affects the electrostatic interaction
of histones with DNA. In this sense, acetylation of lysine e-amino
residue turns a positive charge into a non-charged chemical
group and this is supposed to open chromatin by weakening
DNA-histone interactions [57]. Others argue that histone tail
modifications may modulate internucleosomal interactions or
act as adaptors for the binding of specific effectors, that in turn
act as chromatin remodelers, transcription regulators, etcetera
[58].
Nucleosomes act as physical roadblocks for progression of tran-
scription, as DNA wrapped around histones has to be unwrapped
for RNAPII to transcribe it. Indeed, the first nucleosome in the tran-
scribed region (also named the +1 nucleosome) is highly posi-
tioned and has a role in promoter proximal pausing [59]. RNAPII
dynamics through nucleosomes has been studied in detail by Car-
los Bustamante’s group, with an in vitro system of transcription
[60]. In this study, they observed that nucleosomes impose a bar-
rier for RNAPII progression, increasing pause density and durationand decreasing RNAPII apparent velocity. According to their model,
when RNAPII finds a nucleosome on its way along DNA, it tends to
pause and backtrack. RNAPII lacks the ability to unwrap nucleo-
somes, so it has to happen either spontaneously or via the action
of chromatin remodelers. But what happens with the histones
and how do nucleosomes re-assemble when RNAPII transcribes a
region? It has been proposed that DNA forms a loop that allows
DNA behind RNAPII to interact with the histones of partially
unwrapped nucleosomes. This would permit an in cis histone
transfer to DNA, upstream the original position of the nucleosome,
and guarantee the correct re-establishment of nucleosome posi-
tioning after transcription. Other in vitro studies performed by
Michelle D. Wang’s group, suggest that the positive torque exerted
by RNA polymerase on DNA can contribute to destabilize H2A-H2B
dimers from nucleosomes, and thus favor their disassembly in the
way of RNAPII [61]. In any case, nucleosome disassembly and
reassembly in vivo are probably facilitated by the action of chro-
matin remodelers and histone chaperones [62]. In a more recent
publication, Bustamante’s group used their in vitro transcription
system to study in detail the influence of different histone tail
modifications and direct histone-DNA interactions on transcription
[58]. Besides, DNA sequence per se can inhibit the progression of
transcription [63], and this effect seems to be amplified by nucle-
osomes. Nascent RNA, on the other hand, reduces pause duration
and prevents backtracking, as observed when RNase A is added
to this in vitro transcription system [58], probably because it stabi-
lizes the elongation complex. Not to be ignored, our genome
encodes histone variants, such as H2A.Z and H3.3, that can replace
canonical histones and change nucleosome stability, as well as give
place to more compact or loose nucleosome associations, by
changing their chemical properties or recruiting particular remod-
eling factors and histone chaperones [62,64]. Expectedly, there is a
crosstalk between transcription and chromatin remodeling, as
transcription itself can recruit chromatin remodeling factors and
histone modifying proteins [65].
In summary, histone variants and histone tail PTMs can either
silence or activate gene expression and influence alternative splic-
ing depending on their effect on chromatin structure or the factors
they recruit. In this sense, particular PTMs have been characterized
as transcription repressing or activating marks [65]. It is easy to
envision how changes in chromatin compaction can affect alterna-
tive splicing through kinetic coupling with transcription, as a more
closed chromatin will result a more difficult template for RNAPII to
transcribe. In fact, a role of chromatin constitution in alternative
splicing regulation was first shown by our group in 2001. Using a
replicative plasmid harboring an alternative splicing reporter mini-
gene, it was observed that the replication of the plasmid, a process
that results in a correctly structured chromatin within the plasmid,
provokes higher exon inclusion levels in the mature mRNA. These
results suggested that chromatin would impose pauses and delays
in transcript elongation that, in turn, would affect alternative splic-
ing in the paradigm of the kinetic model of coupling [31]. A role of
chromatin structure in alternative splicing was later confirmed by
our group and others. For instance, it was observed that upon neu-
ronal cell depolarization, nucleosomes around the alternative exon
18 of NCAM gene get hyper-acetylated in H3K9 (H3K9ac), leading
to an increase in exon skipping. H3K9ac is a hallmark of relaxed
chromatin and this change in alternative splicing is consistent with
a higher elongation rate of RNAPII modulating alternative splicing
[39]. In turn, fibronectin E33 inclusion is favored by a tighter chro-
matin conformation, driven by siRNA-directed di-methylation of
H3K9me2 and tri-methylation of H3K27 close to the alternative
exon [66]. Another report shows that H3K9 methylation recruits
HP1c, leading to a more compact chromatin due to internucleoso-
mal interactions that, in turn, results in a decrease in RNAPII elon-
gation rate and affects alternative splicing decisions [38]. Finally,
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regulate splicing: MRG15 binds to H3K36me3 and modulates alter-
native splicing events via the recruitment of the splicing factor PTB
to the nascent mRNA [37].
Genome-wide analyses show that nucleosomes are preferen-
tially positioned in exons, which is consistent with the fact that
the average size of an exon is around 150 bp, almost the same
length of DNA that forms part of a nucleosome. Moreover, exonic
nucleosomes are enriched in particular histone marks, as
H3K36me3 [67–69]. Interestingly, there is a negative correlation
between exon positioning, histone marks and the strength of the
splice sites, suggesting these features may help recognize exons
flanked by weak splice sites [69,70]. Despite nucleosomes have a
preference for GC sequences, and human exons have a higher GC
content, the nucleosome enrichment in exons is only partially
explained by this sequence bias [67,69]. Interestingly, this enrich-
ment of nucleosomes in exons is also seen in non-transcribed
genes, suggesting nucleosome marking of exons is independent
of transcription [69]. This feature is conserved across species,
including C. elegans, D. melanogaster and mammals.
Regarding alternative exons, histone marks are reduced when
compared to constitutive exons [71]. This is consistent with his-
tone marks and nucleosomes contributing to exon recognition by
a decrease of elongation rate [11]. For a detailed review on alterna-
tive splicing and chromatin modifications refer to [72].
4.2. DNA methylation
Eukaryotes can methylate DNA cytosines in C5 (5mC). In partic-
ular, 5mC is widespread in vertebrate genomes, contrasting with
what happens in plants and invertebrates, where it is restricted
to repetitive DNA sequences and actively transcribed loci. In mam-
mals, methylation occurs primarily on CpG dinucleotides, although
in neurons, embryonic stem cells and oocytes it also happens in
other sites. CpG islands are genomic elements enriched in mam-
malian promoters and their hypermethylation leads to the repres-
sion of the downstream gene, presumably due to a more
compacted chromatin. Indeed, heavily methylated DNA is observed
in transcriptionally repressed loci, like imprinted genes and inac-
tive X chromosome in mammals, and it is a hallmark of constitu-
tive heterochromatin [73].
DNA methylation is established and maintained by DNA
methyltransferases (DNMTs), a family of highly conserved pro-
teins. DNA demethylation competes with DNA methylation and it
can happen in a passive way, due to inefficient remethylation after
replication or by an active pathway comprising the progressive
oxidation of 5mC ending in the reestablishment of unmethylated
cytosine [73]. Refer to [74] for an up-to-date review on DNA
methylation, that includes the proposal of an stochastic DNA
methylation model.
DNA methylation has been shown to influence alternative splic-
ing decisions. In this sense, two articles show opposite effects of
DNA methylation. Whereas DNA methylation of sequences coding
for alternative exons can promote exon inclusion via recruitment
of MeCP2 [75], DNAmethylation can also promote alternative exon
skipping by preventing the recruitment of the chromatin-
insulating factor CTCF, that would act as a roadblock for RNAPII
elongation [76].
4.3. DNA conformation
The canonical structure of DNA, published in 1953 by Watson
and Crick, also called B-DNA structure, is a double helical right-
handed molecule and the most common conformation adopted
in the eukaryotic cell nucleus. Nevertheless, two other double heli-
cal DNA structures have been described: A-DNA, a right-handed,broader and more compressed along its axis conformation; and
Z-DNA, a left-handed, thinner and less compressed conformation.
These three DNA forms differ in many parameters, including angles
formed by the base pairs, conformation of the pentose ring, geom-
etry of the glycosyl bond and depth of minor and major grooves,
among others [77]. It is thus expectable that DNA conformation
will affect the quality and quantity of DNA interactors, as well as
the transcriptional process [78]. Other non-B DNA structures will
be discussed below.
A- and B-DNA actually constitute a family of conformations
with intermediate structures [79]. Though in vitro A-DNA confor-
mation is favored by low humidity and high salt concentration, it
does also occur in vivo. For example, the TATA box consensus
sequence is supposed to be prone to adopt an A-like conformation,
and this conformation is an important intermediate step in the for-
mation of the characteristic structure induced after the binding of
TBP [80]. On the other hand, Z-DNA formation implies a radical
change in DNA structure, passing from a right-handed to a left-
handed double helix, and thus contributes to alleviate negative
supercoiling. Its formation is specially biased by the sequence,
occurring in (CG)n and (TG)n tracts [81]. Additionally, DNA methy-
lation on C5 of cytosines lowers the free energy difference from B-
DNA to Z-DNA, resulting in an increase on Z-DNA population [82].
There are proteins that specifically bind to Z-DNA and the first one
to be described was ADAR1, a dsRNA adenosine deaminase. This
protein is recruited to Z-DNA formed in the proximity of a tran-
scribing RNAPII, and edits the nascent RNA turning adenosines into
inosines [81]. It is important to note that DNA conformations coex-
ist within the same chromosome, and even within the same gene.
Thus, while transition from B to A-DNA can be explained by a tight-
ening of the DNA helix, B to Z-DNA transition implies an inversion
in the helix sense, that results in two bases extruded from the dou-
ble helix [83].
As Z-DNA, there are other non-B DNA conformations that
reduce DNA molecule free energy due to negative supercoiling, i.
e. cruciform DNA, triplex (or H-DNA), G-quadruplex and slipped
DNA [1]. The formation of these structures is dependent on the
DNA sequence, being cruciforms formed in inverted repeats (i.e.
palindromic sequences) of more than 6 nucleotides long. Triplex
DNA is formed in mirror repeats, in which the double helix of
one of the repeats melts and one strand of it forms a triple helix
stabilized by Hoogsteen bonds (a type of hydrogen bonds between
bases different from those described byWatson and Crick) with the
other repeat, leaving a single strand of DNA. G-quadruplexes are
non-helical structures formed by guanine tetrads interacting by
Hoogsteen bonds, stacked and stabilized by monovalent cations.
Slipped DNA forms in DNA repeats with no spacer and creates
two strands of single-stranded DNA [84,85]. Non-B DNA conforma-
tions differ from the B-DNA substrate RNAPII uses as template, so
they may play a role in alternative splicing by affecting elongation
rates or inducing pauses in transcription. Additionally, these struc-
tures have effects on the chromatin state. Nucleosome formation is
impaired in non-B DNA, both due to its physical characteristics and
also because of the specific proteins that bind to these particular
structures [86].
Many studies have been performed to assess a role for triplex
formation on transcription. As it is deeply reviewed by Van Dyke
[87], triplex DNA can either impede the binding of specific factors
to their target DNA sequences, thus promoting or inhibiting tran-
scription, or have a direct effect by arresting RNAPII elongation.
Indeed, a wide variety of in vitro and in vivo studies suggest a tran-
scriptional inhibitory role for triplex DNA. This was observed
invading specific DNA sequences with triplex forming oligonu-
cleotides (TFOs), or by assessing the roles of the naturally occurring
inter- or intra-molecular triplexes. Indeed, a recent publication of
the Hanawalt group shows that triplex DNA can block RNAP T7
N. Nieto Moreno et al. / FEBS Letters 589 (2015) 3370–3378 3375elongation in vitro [88]. Additionally, triplex DNA can act as an
anchor for the binding of chromatin modifying factors [89].
Regarding G-quadruplexes, when located in the template strand
they may cause a steric blockage of transcription, impeding RNAPII
elongation [85]. G-quadruplex forming sequences (G4 motifs) are
located in around 50% of our gene promoters with a particular
enrichment in oncogenes and regulatory genes versus housekeep-
ing or tumor suppressor genes [90], and are predominant in the
non-template strand of our genes. A crosstalk between non-B
DNA and chromatin features seems likely, as nucleosomes and
CpG methylation are depleted in G4 motifs [91], and cells deficient
in Rev1, a protein involved in G-quadruplex denaturation during
replication, loose certain histone marks around G4 motifs, such
as H3K4me3 and H3K9/14ac [92]. Besides, as well as
G-quadruplexes or triplex DNA, the single-stranded DNA that
results from the formation of these structures can recruit particular
factors that promote or inhibit transcription, as it happens with
hnRNP K binding a C-rich tract of the VEGF promoter [93]. Refer
to [86] for a detailed review on how non-B DNA structures might
interfere with transcription.
Although scarce evidence exists on whether non-B DNA confor-
mations affect alternative splicing, the fact that non-B DNA has
been shown to play roles in intragenic transcriptional dynamics
makes investigation of alternative splicing regulatory mechanisms
involving non-B DNA timely and interesting. A bioinformatics anal-
ysis showed a strong genome-wide correlation between non-B
DNA forming sequences and alternative exons, suggesting that
alternative splicing could be regulated by non-B DNA structures,
either acting as a roadblock for RNAPII or as a platform for the
binding of regulatory factors [84]. In this sense, it was shown that
the splicing factor U2AF65 has affinity to triplex DNA [94]. How-
ever, not only proteins binding to these non-canonical nucleic acid
structures may play a role in transcription and splicing: activity ofA 
C 
B 
RNAPII 
D 
Fig. 2. Template features that act as roadblocks for RNAPII transcription progression c
regulatory sequences to be recognized. (A) DNA sequences that recruit specific proteins, s
compaction and histone PTMs [39,66]. (C) Nucleosomes positioned in exons [60,69]. (D)helicases that resolve these structures, such as XPD/XPB [95],
ChIR1 [96], BLM [97] or FANCJ [98], may modulate alternative
splicing decisions. Further research has to be made in this area to
get a clearer picture of the role of non-canonical nucleic acid struc-
tures in alternative splicing.
Transcription of G-rich sequences tends to form a highly stable
DNA:RNA hybrid named R-loop. The co-transcriptional recruit-
ment of splicing factors to the nascent pre-mRNA restricts its inter-
actions with the template DNA and prevents R-loop formation,
which can in turn be resolved by RNase H activity or by specific
helicases [99]. These DNA:RNA hybrids can have an effect on tran-
scription. In fact, Hanawalt and colleagues demonstrated that a G-
rich homopurine stretch at the non-template strand blocks tran-
scription by T7 RNA polymerase in vitro, presumably via the for-
mation of R-loops. However, the mechanism is not clear, and it
may be a consequence of RNA polymerase destabilization by a
stable R-loop formation, or a collision of RNA polymerase with
RNA:DNA hybrids formed previously in the template DNA [63].
Besides, R-loop formation can lead to the deposition of repressive
chromatin marks as observed in mammalian gene terminators,
thereby affecting transcription in an indirect manner [100]. There-
fore, one could speculate that R-loop formation might lead to
changes in alternative splicing decisions by affecting RNAPII elon-
gation rate, either directly acting as roadblocks, or by inducing
changes in chromatin constitution.
Importantly, these non-canonical structures are not exclusive of
DNA and also occur in RNA. Regarding non-canonical RNA
structures, splicing factors such as SRSF1, SRSF9 and proteins of
the hnRNP family have been reported to interact with RNA
G-quadruplexes [101]. It has been reported that the formation of
an RNA G-quadruplex in intron 3 of the nascent mRNA of the gene
TP53 promotes intron 2 excision [102]. As well, it was shown that
an RNA G-quadruplex increases splicing efficiency in PAX9 intron 1MAZ P 
MAZ 
HP1 
CH3 CH3 
CH3 
RNAPII 
RNAPII 
RNAPII 
an affect alternative splicing decisions by changing the time-window for splicing
uch as the MAZ sequences that bind the MAZ zinc finger protein [40]. (B) Chromatin
Non-B DNA structures [86].
3376 N. Nieto Moreno et al. / FEBS Letters 589 (2015) 3370–3378[103]. RNA-binding proteins of the AFF family can modulate alter-
native splicing of a reporter minigene harboring an RNA G-
quadruplex [104].
5. Concluding remarks
Coupling of transcription and mRNA splicing has been vastly
confirmed by multiple approaches. This coupling is due to the
recruitment of factors that modulate transcription and splicing,
as well as a consequence of the kinetics of transcription [26]. The
rate at which RNAPII transcribes can be modulated either by
trans- or cis-acting factors including the template DNA or proteins
bound to it. On the other hand, template features can participate in
the recruitment of factors that modulate splicing directly [94]. Up
to this point it becomes evident that the recruitment and the
kinetic coupling models are not intertwined, but probably repre-
sent two faces of the same process.
In this review we went through the existing evidence of how
these cis-acting factors modulate transcription. These factors can
be classified in 4 different categories, i.e. (A) proteins that bind to
DNA, (B) chromatin compaction and histone PTMs, (C) positioned
nucleosomes and (D) template DNA conformation (Fig. 2). All of
them have been shown to modulate transcription acting as road-
blocks for RNAPII progression. Still, we are aware that the actual
scenario might be more complicated, and a combination of these
factors may be playing a role in alternative splicing decisions.
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